4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-24-003305
CVP, Chief Financial Officer sold 7,255 shares at $85.59 ($620,923)
- CVP, Chief Financial Officer acquired 7,255 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ullem Scott B. · CVP, Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-29 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,255 | $36.75 | $266,621 | 26,329 | D |
| 2024-02-29 | Sale : show line 2 in the form 10b5-1 | −7,255 | $85.59 | $620,923 | 19,074 | D |
| Open-market sales · 7,255 sh · avg $85.59 · $620,923 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-02-29 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −7,255 | $36.75 | 2024-05-10 | 7,255 | 14,505 | D |
Loading xslF345X05/doc4.xml…